These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [A 81-year old man of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody-positive myopathy associated with lung adenocarcinoma cancer]. Yamanaka N; Sato R; Oishi M; Shimizu F; Koga M; Hoshii Y; Kanda T Rinsho Shinkeigaku; 2021 Jul; 61(7):456-460. PubMed ID: 34148931 [TBL] [Abstract][Full Text] [Related]
45. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan. Watanabe Y; Suzuki S; Nishimura H; Murata KY; Kurashige T; Ikawa M; Asahi M; Konishi H; Mitsuma S; Kawabata S; Suzuki N; Nishino I Medicine (Baltimore); 2015 Jan; 94(4):e416. PubMed ID: 25634171 [TBL] [Abstract][Full Text] [Related]
46. Autoimmune necrotising myopathy and HMGCR antibodies. Karunaratne K; Amiras D; Pickering MC; Hofer M; Viegas S Pract Neurol; 2018 Apr; 18(2):151-155. PubMed ID: 29439058 [TBL] [Abstract][Full Text] [Related]
47. Mitochondrial dysfunction in anti-3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) immune-mediated necrotising myopathy. Acosta IJ; Hofer M; Brady S Neuromuscul Disord; 2022 May; 32(5):441-444. PubMed ID: 35487868 [TBL] [Abstract][Full Text] [Related]
48. Autoantibodies to the survival of motor neuron complex in a patient with necrotizing autoimmune myopathy. Amlani A; Hazlewood GS; Hamilton L; Satoh M; Fritzler MJ Rheumatology (Oxford); 2018 Jan; 57(1):199-200. PubMed ID: 29088473 [No Abstract] [Full Text] [Related]
49. Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies. Arouche-Delaperche L; Allenbach Y; Amelin D; Preusse C; Mouly V; Mauhin W; Tchoupou GD; Drouot L; Boyer O; Stenzel W; Butler-Browne G; Benveniste O Ann Neurol; 2017 Apr; 81(4):538-548. PubMed ID: 28224701 [TBL] [Abstract][Full Text] [Related]
50. Treatment experience of Taiwanese patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase myopathy. Liang WC; Wang CH; Chen WZ; Kuo YT; Lin HF; Suzuki S; Nishino I; Jong YJ Kaohsiung J Med Sci; 2020 Aug; 36(8):649-655. PubMed ID: 32666706 [TBL] [Abstract][Full Text] [Related]
51. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy. Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697 [TBL] [Abstract][Full Text] [Related]